Navigation Links
Amended Chairman's Mark Sets Stage for "Hitting 'Bulls-eye' in Health Reform"
Date:10/9/2009

Analysis of Health Reform Legislation Shows Shift Towards Health, Wellness; "A la Carte" Approach Could Limit Impact, Expert Cautions

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ --The Partnership to Fight Chronic Disease (PFCD) today released an updated comparison of chronic care provisions contained within health reform legislation to reflect the amended Senate Finance Committee proposal. The amended "Chairman's Mark" includes numerous provisions to prevent and manage chronic disease, the top cost driver in health care, as do the two other major pieces of health reform legislation under consideration in Congress.

"For the first time in a national debate on health care, preventing and managing chronic disease is being recognized as a health reform priority that holds the key to helping improve health and reduce costs over the long-term," said Ken Thorpe, Ph.D., PFCD Executive Director. "And, I think the legislation coming out of the Finance Committee is a great example of the type of comprehensive change needed to set the stage for Congress to hit the 'bulls-eye' in health reform this year."

"I'm also encouraged that the Congressional Budget Office's cost estimate of the bill shows that we can improve quality and expand coverage and while still achieving cost-savings," Thorpe added, noting that the amended Chairman's Mark invests nearly $5 billion in prevention initiatives to reduce rates of common and costly chronic illnesses, in addition to funding a new prevention and wellness trust fund.

"However, as legislation moves forward, we need to remain cognizant of the importance of taking a holistic, as opposed to an 'a la carte,' approach to delivery system reforms. Well-coordinated, comprehensive changes are required to improve prevention, disease management, coordination of care, and care transitions or else we won't be able to effectively control costs -- especially in Medicare."

PFCD's newly-released legislative comparison, "Hitting the 'Bulls-eye' in Health Reform: Controlling Chronic Disease to Reduce Cost and Improve Quality," which is available on the PFCD Web site, summarizes the unprecedented variety of reform initiatives aimed to improving chronic disease prevention and management. It also compares the various bills on PFCD's five policy priorities, "Ideas for Change," which state that meaningful health reform must:

  • Advance sustainable "next generation" chronic disease prevention, early intervention, and management models throughout the health care system and public health infrastructure
  • Promote healthy lifestyles and disease prevention and management in every community
  • Encourage and reward continuous advances in clinical practice and research that improve the quality of care for those with costly chronic diseases
  • Accelerate improvements in the quality and availability of health information technology (HIT) throughout the health care system
  • Reduce health disparities by focusing on barriers to good health

About the Partnership to Fight Chronic Disease:

The PFCD is a national coalition of more than 120 patient, provider, community, business and labor groups, committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: poorly prevented and mismanaged chronic disease. For more information about the PFCD and its partners, please visit: http://www.fightchronicdisease.org.

SOURCE Partnership to Fight Chronic Disease


'/>"/>
SOURCE Partnership to Fight Chronic Disease
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ZS Associates: Synygys Amended Complaint Has No Merit
2. CareFusion Files Amended Form 10 Registration Statement With SEC
3. Bioniche Revolving Credit Facility Maturity Date Amended
4. Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
5. Haemacure financing receives shareholder consent - Series B Warrants are amended
6. TeamStaff Announces Amended Revolving Credit Facility with Sovereign Business Capital
7. Heska Announces Amended Agreement With AgriLabs
8. NutraDyne, Inc. Closes Amended Exchange Agreement With Changchun Yongxin Dirui Medical Co., Ltd.
9. Boston Scientific Announces Amended Agreement to Settle Product Lawsuits
10. Plaintiffs Obtain $240 Million Amended Settlement In Guidant Defibrillators Products Liability Litigation
11. The Rev. Michael J. OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/25/2017)... ... 25, 2017 , ... Getting earned media coverage meaningful for Garden Media Group's ... through the year, Garden Media aims to provide material helpful to clients’ goals and ... pitching client’s key messages to gain coveted media placements, Garden Media wows clients ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company ... in children, today reported financial results for the ... 2016 and provided an update on its corporate ... progress during the fourth quarter of 2016 through ... safety study, and with our lead development candidate, ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets ... Market, 2017-2027" report to their offering. ... The Cell Therapy Manufacturing ... growing market of cell therapy manufacturing and focuses both on ... These therapies are anticipated to emerge as viable alternatives to ...
(Date:3/24/2017)... March 24, 2017  Zymo Research Corp., ... Hamilton Robotics, Inc., who designs, manufactures and ... collaboration that teams Zymo Research,s DNA methylation ... DNA extraction products with Hamilton,s high-throughput automation ... methods for microbiomics and RNA isolation for ...
Breaking Medicine Technology: